Valneva SE (VALN) Exchange Rate Effect (2021 - 2026)
Valneva SE (VALN) posted quarterly Exchange Rate Effect of $389180.4 for Q1 2026, up 157.97% year-on-year from $150864.9 in Q1 2025, and up 6.21% on a QoQ basis from $366421.3 in Q4 2025.
Valneva SE (VALN) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Exchange Rate Effect for 6 consecutive years, with $389180.4 the latest figure, recorded in Q1 2026.
- Quarterly Exchange Rate Effect rose 157.97% year-over-year to $389180.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 265.99% YoY) and the FY2025 annual result came in at -$3.9 million, down 287.58% from the prior year.
- Exchange Rate Effect grew to $389180.4 in Q1 2026 per VALN's latest filing, from $366421.3 in the prior quarter.
- Over the last five years, Exchange Rate Effect for VALN reached as high as $661.9 million in Q3 2023 and fell as low as -$661.9 million in Q2 2023.
- A 5-year average of -$152352.0 and a median of -$47794.1 in 2025 frame the typical range for Exchange Rate Effect.
- The largest YoY upside for Exchange Rate Effect was 54621.07% in 2023 against a maximum downside of 67892.07% in 2023.
- Year by year, Exchange Rate Effect stood at -$3.0 million in 2022, then surged by 104.2% to $126312.9 in 2023, then soared by 1983.78% to $2.6 million in 2024, then plunged by 86.08% to $366421.3 in 2025, then advanced by 6.21% to $389180.4 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $389180.4, $366421.3, and -$47794.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | 389,180.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 389,180.36 |
| Mar 31, 2026 | 389,180.36 |
| Dec 31, 2025 | 366,421.28 |
| Dec 31, 2025 | 366,421.28 |
| Sep 30, 2025 | -47,794.08 |
| Sep 30, 2025 | -47,794.08 |
| Jun 30, 2025 | -3.51 Mn |
| Jun 30, 2025 | -3.51 Mn |
| Mar 31, 2025 | -671,393.02 |
| Mar 31, 2025 | -671,393.02 |
| Dec 31, 2024 | 2.63 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | -1.23 Mn |
| Sep 30, 2024 | -1.23 Mn |
| Jun 30, 2024 | 954,743.63 |
| Jun 30, 2024 | 954,743.63 |
| Mar 31, 2024 | -300,419.93 |
| Mar 31, 2024 | -300,419.93 |
| Dec 31, 2023 | 126,312.92 |
| Dec 31, 2023 | 126,312.92 |